Abstract
Epileptic seizure is a neurological condition in which brief to long episodes of vigorous shaking, convulsions, blackouts, fainting, unresponsiveness, jerks, etc. occur in the patients. Current treatment approaches are anti-seizure medicines, which patients are bound to take throughout life. These medications are mostly not able to reverse or eradicate the condition. Vedic literature recommends Yagya as a therapy for mental conditions similar to mania, seizure, etc. Yagya-Therapy provides pulmonary inhalation of medicinal-smoke of multiple herbs (generated through oblation in fire along with chanting of Vedic hymns), which have the potential for seizure treatment. A case study is being reported wherein Yagya-Therapy was prescribed to an epileptic seizure patient. Before the start of Yagya-Therapy, the patient (Male/65 years) had been suffering from epileptic seizures (~8-10 episodes annually) since ~3 years (pre-observation). Subsequently, the patient has been doing Yagya-Therapy since past ~3.5 years, wherein only 2-3 episodes occurred during the first year, that too during sleep only, and after that no seizures have been experienced. All this time, the patient continued to take the allopathic medication that he was taking earlier. Thus, Yagya-Therapy can be an effective treatment option for epileptic seizure patients.
References
Amudhan S, Gururaj G, Satishchandra P. Epilepsy in India I: Epidemiology and public health. Ann Indian Acad Neurol. 2015;18(3):263–77. https://doi.org/10.4103/0972-2327.160093
Andlin-Sobocki P, Jonsson B, Wittchen H-U, Olesen J. Cost of disorders of the brain in Europe. Eur J Neurol. 2005;12(s1):1–27. https://doi.org/10.1111/j.1468-1331.2005.01202.x
Ivanova JI, Birnbaum HG, Kidolezi Y, Qiu Y, Mallett D, Caleo S. Direct and indirect costs associated with epileptic partial onset seizures among the privately insured in the United States. Epilepsia. 2010;51(5):838–44. https://doi.org/10.1111/j.1528-1167.2009.02422.x
Leonardi M, Ustun TB. The global burden of epilepsy. Epilepsia. 2002;43 Suppl 6:21–5. https://doi.org/10.1046/j.1528-1157.43.s.6.11.x
Hixson JD. Stopping antiepileptic drugs: when and why? Curr Treat Options Neurol. 2010;12(5):434–42. https://doi.org/10.1007/s11940-010-0083-8
Brahmavarchas, editor. Yagyachikitsa-yagyopathy: ek samagra evam divya chikitsa paddhati (Hindi). In: Yagya Chikitsa. Shri Vedmata Gayatri Trust, Shantikunj, Haridwar (Uttarakhand), 249411, India; 2010:15–35
Pandya P. Applied Science of Yagya for Health & Environment. Shri Vedmata Gayatri Trust, Shantikunj, Haridwar (Uttarakhand), 249411, India; 2009:1-117. Available from: www.awgp.org
Joshi RR, Raghuvanshi M, Pandya P. Yagyopathy versus oral and iv drug administration: evaluation for pulmonary tuberculosis using compartment modeling. J Biol Syst. 2006;14(03):463–89. https://doi.org/10.1142/S0218339006001891
Patel V, Mishra A, Shrivastav V. Pulmonary inhalation of medicinal smokes– an aspect of yagya therapy: an effective therapeutic application and efficient drug delivery model of multiple herbs. In: National Medicinal Plants Board (Ministry of AYUSH, Govt Of India) sponsored National conference on Recent Advances in Ayurvedic Herbal Medicine -Dehradun. 2017:16th Sept
Mohagheghzadeh A, Faridi P, Shams-Ardakani M, Ghasemi Y. Medicinal smokes. J Ethnopharmacol. 2006 Nov;108(2):161–84. https://doi.org/10.1016/j.jep.2006.09.005
Verma S, Mishra A, Shrivastava V. Yagya Therapy in Vedic and Ayurvedic Literature: A Preliminary exploration. Interdiscip J Yagya Res. 2018;1(1):15–20. https://doi.org/10.36018/ijyr.v1i1.7
Tewary R, Mishra JK. Hawan—An effective method to reduce fungal load at small work places. Aerobiologia (Bologna). 1997;13(2):135–8. https://doi.org/10.1007/BF02694430
Saxena M, Kumar B, Matharu S. Impact of Yagya on Particulate Matters. Interdiscip J Yagya Res. 2018;1(1):01-8. https://doi.org/10.36018/ijyr.v1i1.5
Jain S, Tandon PN. Ayurvedic medicine and Indian literature on epilepsy. Neurol Asia. 2004;9(Supplement 1):57–8. Available from: http://www.neurology-asia.org/articles/20043_057.pdf
Raghuvanshi M, Pandya P, Joshi RR. Yagyopathic Herbal Treatment of Pulmonary Tuberculosis Symptoms: A Clinical Trial. Altern Complement Ther. 2004;10(2):101–5. https://doi.org/10.1089/107628004773933352
Raghuvanshi M, Pandya P, Joshi RR. In-vitro Testing Of An Ethnobotanical Inhalation Therapy Against Pulmonary Tuberculosis. Phytotherapie. 2009;7(5):243–9. https://doi.org/10.1007/s10298-009-0413-8
Sharma S. Yagya Chikitsa Dwara Manasik Swasthya Par Padane Vale Prabhav Ka Adhyayan (Hindi) (Dissertation). Dev Sanskriti Vishwavidyalaya, Shantikunj, Haridwar, Uttarakhand, India; 2009
Sharma P, Khokhar CP, Manchanda SC, Sharma N. Yagya Therapy for Managing Inferiority & Insecurity feeling of HIV + / AIDS Patients. Dev Sanskriti Interdiscip Int J. 2012;01:70–7
Mishra A, Batham L, Shrivastava V. Yagya Therapy as supportive care in cancer patients improved quality of life: Case studies. Interdiscip J Yagya Res. 2018;1(1):26–33. https://doi.org/10.36018/ijyr.v1i1.3
Bansal P, Kaur R, Gupta V, Kumar S, Kaur R. Is There Any Scientific Basis of in Epilepsy-Prevention/Cure? J Epilepsy Res. 2015;5(2):33–45. https://doi.org/10.14581/jer.15009
Brahmavarchas, editor. Yagya Chikitsa. 1st ed. Shri Vedmata Gayatri Trust, Shantikunj, Haridwar (Uttarakhand), 249411, India; 2010;1-368.
Vedmurti Taponishtha Pt. Shriram Sharma Acharya. Sankshipt Gayatri hawan vidhi (Hindi). Revision. Yug nirman yojana vistar trust, Gayatri Tapobhumi, Mathura; 2012:1-49
Sharma P. Dravyaguna Vijnana - Volume II (Hindi). Chaukhambha Bharati Academy, Varanasi, Uttar Pradesh, India; 2001
Liu W, Ge T, Pan Z, Leng Y, Lv J, Li B. The effects of herbal medicine on epilepsy. Oncotarget. 2017;8(29):48385-97. https://doi.org/10.18632/oncotarget.16801
Kiasalari Z, Khalili M, Roghani M, Sadeghian A. Antiepileptic and Antioxidant Effect of Brassica nigra on Pentylenetetrazol-Induced Kindling in Mice. Iran J Pharm Res IJPR. 2012;11(4):1209–17. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24250555
Kaur M, Goel RK. Anti-Convulsant Activity of Boerhaavia diffusa: Plausible Role of Calcium Channel Antagonism. Evid Based Complement Alternat Med. 2011;9:310420. https://doi.org/10.1093/ecam/nep192
Venkataraghavan S, Rajagopalan V, Srinivasan K. Study of doshic involvement in apasmara (epilepsy) and its utility. Anc Sci Life. 1987;6(3):138–47. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22557563
Tripathi M, Maheshwari M, Jain S, Srivastava P. Ayurvedic medicine and epilepsy. Neurological Journal of Southeast Asia. 2000;5:1-4
Brahmavarchas, editor. Yagya se rog-nivaran evam bal-samvarddhan ke do labh. In: Yagya- ek samagra upchar-prakriya (Pt Shriram Sharma Acharya Vangmay No 25). Akhand Jyoti Sansthan, Mathura-281003; 1994:1–12.6. Available from: www.literature.awgp.org
Pandya NT, Jani P, Vanza J, Tandel H. Solid lipid nanoparticles as an efficient drug delivery system of olmesartan medoxomil for the treatment of hypertension. Colloids Surfaces B Biointerfaces. 2018;165:37–44. https://doi.org/10.1016/j.colsurfb.2018.02.011
This work is licensed under a Creative Commons Attribution 4.0 International License.